[ Price : $8.95]
Federal Register notice: FDA announces that a priority review voucher was redeemed 6/16 by AbbVie for a supplemental BLA for Skyri...[ Price : $8.95]
FDA tells BioMarin Pharmaceutical that it no longer plans to hold an advisory committee meeting to review the companys resubmitted...[ Price : $8.95]
FDA says the Baxter Hillrom recall of WatchCare Incontinence Management Systems is Class 1.[ Price : $8.95]
Three Ropes & Gray attorneys describe some of the issues in a long-awaited FDA final guidance on clinical decision support softwar...[ Price : $8.95]
FDA probes the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients treated with Am...[ Price : $8.95]
Federal Register notice: FDA is identifying two bulk drug substances that it has considered and proposes to include on its list of...[ Price : $8.95]
The FDA Modeling and Simulation Working Group issues a report on how modeling and simulation are used within and across FDA Center...[ Price : $8.95]
At FDAs request, GSK is withdrawing the accelerated approval for Blenrep (belantamab mafodotin-blmf) due to the therapys poor show...